We recently published an article titled Micro-, Small-Cap Firms Dominate Market Rally. In this article, we are going to take a look at where Tonix Pharmaceuticals Holding Corp. (NASDAQ:TNXP) stands against the other stocks.

The stock market pulled back to the red territory on Thursday, with all major indices posting significant losses as tariff threats continued to rattle investors.

The tech-heavy Nasdaq posted the largest loss, down 2.61 percent, followed by the S&P 500 with 1.78 percent, and the Dow Jones with 0.99 percent.

On Thursday, 10 micro and small-cap companies defied a broader market decline, with their share prices jumping by as much as double digits. One company stood out, soaring more than 300 percent during the session.

To come up with Thursday’s top performers, we considered the stocks with the highest day change performance.

A scientist in a lab coat working with a microscope, researching a biopharmaceutical solution.

Tonix Pharmaceuticals Holding Corp. (NASDAQ:TNXP)

Shares of Tonix Pharmaceuticals Holding Corp. (NASDAQ:TNXP) jumped for a third day on Thursday, adding 33.49 percent to its valuation to close at $14.63 apiece as investors gobbled up shares in the company ahead of an investor summit next week.

Tonix Pharmaceuticals Holding Corp. (NASDAQ:TNXP), a fully integrated biopharmaceutical firm, said that it would present at the 2025 Virtual Investor Summit on Tuesday, March 11, where investors would look out for cues and updates on its TNX-102 SL, a priority product candidate that aims to manage fibromyalgia.

Tonix Pharmaceuticals Holding Corp. (NASDAQ:TNXP) said it expects to receive the decision of the Food and Drug Administration on the marketing authorization of the product on August 15, 2025.

Apart from TNX-102 SL, its portfolio also includes TNX-1300, a biologic in Phase 2 development designed to treat cocaine intoxication.

Overall TNXP ranks 3rd on our list of Thursday's top performers. While we acknowledge the potential of TNXP as an investment, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns and doing so within a shorter time frame. If you are looking for an AI stock that is more promising than TNXP but trades at less than 5 times its earnings, check out our report about the cheapest AI stock.

 

READ NEXT: 20 Best AI Stocks To Buy Now and Complete List of 59 AI Companies Under $2 Billion in Market Cap

 

Disclosure: None. This article is originally published at Insider Monkey.